<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Albireo Pharma, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Albireo Pharma, Inc.

    Albireo is a clinical-stage biopharmaceutical company focused on the development and potential commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. Our parent company, Albireo Pharma, Inc., is located in Boston, Massachusetts and our key operating subsidiary, Albireo AB, is located in Gothenburg, Sweden. We were spun out from AstraZeneca in 2008. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Ron Cooper
    • FOUNDED
      2003
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Eagle Pharmaceuticals, Inc.

    Eagle Pharmaceuticals, Inc.

    Eagle is a specialty pharmaceutical company working to advance safe and efficient ...

    Eagle is a specialty pharmaceutical company wor...

    Filing Type:    PU
    Aethlon Medical, Inc.

    Aethlon Medical, Inc.

    At Aethlon Medical, we are a leading developer of immunotherapeutic technologies t...

    At Aethlon Medical, we are a leading developer ...

    Filing Type:    PU
    Maternova, Inc.

    Maternova, Inc.

    Maternova, Inc. is the trusted resource for cutting edge medical innovations in ne...

    Maternova, Inc. is the trusted resource for cut...

    Amount Raised:    $104,976.00
    Fundraising Status:    EC
    Filing Type:    CF
    KalVista Pharmaceuticals, Inc.

    KalVista Pharmaceuticals, Inc.

    KalVista is a pharmaceutical company focused on the discovery, development and com...

    KalVista is a pharmaceutical company focused on...

    Filing Type:    PU
    GENFIT S.A.

    GENFIT S.A.

    GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and de...

    GENFIT is a late-stage biopharmaceutical compan...

    Filing Type:    PU
    Aptinyx Inc.

    Aptinyx Inc.

    Aptinyx Inc. is a clinical-stage biopharmaceutical company discovering and develop...

    Aptinyx Inc. is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Tiziana Life Sciences plc

    Tiziana Life Sciences plc

    Tiziana Life Sciences is a dual-listed (NASDAQ:TLSA, AIM:TILS) clinical stage biot...

    Tiziana Life Sciences is a dual-listed (NASDAQ:...

    Filing Type:    PU
    Conatus Pharmaceuticals Inc.

    Conatus Pharmaceuticals Inc.

    Conatus Pharmaceuticals is a biotechnology company focused on the development and ...

    Conatus Pharmaceuticals is a biotechnology comp...

    Filing Type:    PU
    Galmed Pharmaceuticals Ltd.

    Galmed Pharmaceuticals Ltd.

    Galmed is a clinical-stage biopharmaceutical company focused on the development of...

    Galmed is a clinical-stage biopharmaceutical co...

    Filing Type:    PU
    Protagonist Therapeutics, Inc.

    Protagonist Therapeutics, Inc.

    Protagonist Therapeutics is a clinical stage biopharmaceutical company that utiliz...

    Protagonist Therapeutics is a clinical stage bi...

    Filing Type:    PU
    Evoke Pharma, Inc.

    Evoke Pharma, Inc.

    Evoke Pharma, Inc. (NASDAQ: EVOK) is a specialty pharmaceutical company focused pr...

    Evoke Pharma, Inc. (NASDAQ: EVOK) is a specialt...

    Filing Type:    PU
    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc. is a microbiome therapeutics platform company developing ...

    Seres Therapeutics, Inc. is a microbiome therap...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.